Comparing No Mechanical Bowel Preparation With Oral Antibiotics Alone in Patients Undergoing Elective Colon Surgery
Launched by OTTAWA HOSPITAL RESEARCH INSTITUTE · Sep 6, 2018
Trial Information
Current as of July 05, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called REaCT NSQIP, is studying the effectiveness of two different ways to prepare patients for elective colon surgery. Specifically, it compares using oral antibiotics with not using any antibiotics at all. The goal is to see which method helps patients have a better surgery experience and recovery. This trial is open to all adults aged 18 and older who are scheduled for certain types of planned colon surgeries and do not require a specific type of bowel preparation.
To participate, potential volunteers must be able to give their consent and should not have any allergies or bad reactions to the antibiotics being tested. This study is not for patients undergoing emergency surgeries or those who need a different preparation method for their surgery. If you join the trial, you will help researchers learn more about the best practices for preparing the bowel before surgery, which could lead to improved care for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients undergoing elective, non-emergency colon, resection surgery or abdominal perineal resection and no other requirements exists for a mechanical bowel preparation (as determined by the operating surgeon)
- • 18 years of age or older
- • Able to provide oral consent
- Exclusion Criteria:
- • Contraindication to the oral antibiotics, including allergies or adverse reactions to either metronidazole or neomycin
- • Undergoing a rectal resection with a planned anastomosis (these patients will all receive MBP)
- • Emergency surgery where no opportunity to administer preoperative oral antibiotics exists
- • Requirement for a MBP (i.e. rectal resection with pelvic anastomosis, intraoperative colonoscopy, or at the discretion of the treating surgeon
About Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute (OHRI) is a leading academic research institute dedicated to advancing health and healthcare through innovative research and evidence-based practices. Affiliated with The Ottawa Hospital and the University of Ottawa, OHRI fosters a collaborative environment that brings together clinicians, scientists, and trainees to conduct groundbreaking clinical trials and translational research. With a focus on improving patient outcomes, OHRI specializes in a wide range of fields, including cancer, cardiovascular health, and regenerative medicine. The institute is committed to ethical research practices and the dissemination of knowledge to enhance public health and inform healthcare policy.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Toronto, Ontario, Canada
Renfrew, Ontario, Canada
Ottawa, Ontario, Canada
Ottawa, Ontario, Canada
Ottawa, Ontario, Canada
Halifax, Nova Scotia, Canada
Ottawa, Ontario, Canada
Patients applied
Trial Officials
Rebecca Auer, MD
Principal Investigator
Ottawa Hospital Research Institute
Sameer Apte, MD
Principal Investigator
The Ottawa Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials